Ifp Advisors, Inc Biomarin Pharmaceutical Inc Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Ifp Advisors, Inc holds 2,543 shares of BMRN stock, worth $179,484. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,543

Previous 2,570 1.05%

Holding current value

$179,484

Previous $224,000 6.7%

% of portfolio

0.01%

Previous 0.01%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$74.43 - $92.22 $2,009 - $2,489	-27 Reduced 1.05%	2,543 $209,000
Q1 2024 Jul 30, 2024	BUY	$83.81 - $99.0 $3,100 - $3,663	37 Added 1.46%	2,570 $224,000
Q4 2023 Jan 09, 2024	BUY	$76.22 - $98.51 $65,930 - $85,211	865 Added 51.86%	2,533 $244,000
Q3 2023 Oct 12, 2023	SELL	$85.07 - $94.48 $170 - $188	-2 Reduced 0.12%	1,668 $147,000
Q2 2023 Aug 04, 2023	SELL	$86.68 - $100.3 $2,687 - $3,109	-31 Reduced 1.82%	1,670 $144,000
Q1 2023 Apr 18, 2023	SELL	$87.74 - $117.27 $14,301 - $19,115	-163 Reduced 8.74%	1,701 $165,000
Q4 2022 Feb 07, 2023	SELL	$80.93 - $108.63 $6,798 - $9,124	-84 Reduced 4.31%	1,864 $175,000
Q3 2022 Nov 08, 2022	BUY	$82.16 - $96.94 $18,650 - $22,005	227 Added 13.19%	1,948 $181,000
Q2 2022 Sep 06, 2022	BUY	$71.48 - $86.85 $123,017 - $149,468	1,721 New	1,721 $160,000
Q2 2022 Aug 12, 2022	SELL	$71.48 - $86.85 $123,017 - $149,468	-1,721 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$74.28 - $92.69 $22,209 - $27,714	299 Added 21.03%	1,721 $132,000
Q1 2022 Aug 08, 2022	BUY	$74.28 - $92.69 $98,866 - $123,370	1,331 Added 1462.64%	1,422 $109,000
Q4 2021 Jan 12, 2022	SELL	$71.72 - $91.47 $1,147 - $1,463	-16 Reduced 14.95%	91 $8,000
Q3 2021 Oct 06, 2021	SELL	$74.77 - $85.47 $164,494 - $188,034	-2,200 Reduced 95.36%	107 $8,000
Q2 2021 Jul 13, 2021	SELL	$75.51 - $84.79 $679 - $763	-9 Reduced 0.39%	2,307 $193,000
Q1 2021 Apr 30, 2021	BUY	$74.73 - $90.69 $20,700 - $25,121	277 Added 13.59%	2,316 $175,000
Q4 2020 Jan 25, 2021	BUY	$72.61 - $90.2 $8,858 - $11,004	122 Added 6.36%	2,039 $179,000
Q3 2020 Oct 29, 2020	BUY	$71.87 - $131.03 $41,756 - $76,128	581 Added 43.49%	1,917 $143,000
Q2 2020 Aug 05, 2020	SELL	$79.55 - $124.22 $10,102 - $15,775	-127 Reduced 8.68%	1,336 $163,000
Q1 2020 May 12, 2020	BUY	$71.37 - $96.85 $28,976 - $39,321	406 Added 38.41%	1,463 $122,000
Q4 2019 Jan 17, 2020	SELL	$64.27 - $86.37 $1,478 - $1,986	-23 Reduced 2.13%	1,057 $91,000
Q3 2019 Nov 07, 2019	BUY	$67.4 - $85.11 $71,511 - $90,301	1,061 Added 5584.21%	1,080 $76,000
Q1 2019 May 15, 2019	SELL	$84.2 - $98.62 $17,092 - $20,019	-203 Reduced 91.44%	19 $2,000
Q4 2018 Jan 23, 2019	BUY	$80.14 - $106.07 $5,689 - $7,530	71 Added 47.02%	222 $18,000
Q3 2018 Oct 25, 2018	SELL	$93.92 - $105.72 $10,143 - $11,417	-108 Reduced 41.7%	151 $0
Q2 2018 Aug 07, 2018	BUY	$76.01 - $99.03 $9,501 - $12,378	125 Added 93.28%	259 $0
Q1 2018 Jun 03, 2019	BUY	$77.67 - $92.63 $621 - $741	8 Added 6.35%	134 $12,000
Q1 2018 May 09, 2018	SELL	$77.67 - $92.63 $621 - $741	-8 Reduced 5.97%	126 $0
Q4 2017 Jan 24, 2018	SELL	$80.76 - $95.13 $30,931 - $36,434	-383 Reduced 74.08%	134 $0
Q3 2017 Oct 30, 2017	SELL	$80.6 - $94.95 $322 - $379	-4 Reduced 0.77%	517 $48,000
Q2 2017 Jun 03, 2019	BUY	N/A	62 Added 13.51%	521 $47,000
Q1 2017 Jun 03, 2019	SELL	N/A	-25 Reduced 5.17%	459 $40,000
Q4 2016 Jun 03, 2019	SELL	N/A	-63 Reduced 11.52%	484 $40,000
Q2 2016 Jun 03, 2019	BUY	N/A	528 Added 2778.95%	547 $43,000
Q1 2016 Jun 03, 2019	BUY	N/A	19	19 $2,000

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account